Pseudomonas aeruginosa and Surfactant-associated Proteins A and D;Pseudomonas aeruginosa et surfactant rôle de SP-A et SP-D

Medecine et Maladies Infectieuses

Volumn 36, Issue 2, 2006, Pages 63-71

  Faure, K ^a,b   Leberre, R ^a,c   Guery, B ^a,b  

^a France Institut Pasteur de Lille   (France)

^b Service de Réanimation Médicale et Maladies Infectieuses Hôpital Chatiliez Rue du Président Coty   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Pseudomonas aeruginosa; Surfactant associated proteins

Indexed keywords

CHEMOATTRACTANT; COLLECTIN; ELASTASE; FREE RADICAL; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 4; REACTIVE OXYGEN METABOLITE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

CELL ACTIVATION; CYSTIC FIBROSIS; CYTOKINE RELEASE; IN VIVO STUDY; LOBAR PNEUMONIA; LUNG ALVEOLUS CELL; LUNG LAVAGE; MACROPHAGE; PHAGOCYTE; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 33644551863     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.08.011     Document Type: Short Survey

References (64)

1. J. Chastre, and J.Y. Fagon Ventilator-associated pneumonia Am. J. Respir. Crit. Care Med. 165 7 2002 867 903
2. J.Y. Fagon, J. Chastre, Y. Domart, J.L. Trouillet, and C. Gibert Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush Clin. Infect. Dis. 23 3 1996 538 542
3. J.L. Trouillet, J. Chastre, A. Vuagnat, M.L. Joly-Guillou, D. Combaux, and M.C. Dombret Ventilator-associated pneumonia caused by potentially drug-resistant bacteria Am. J. Respir. Crit. Care Med. 157 2 1998 531 539
4. C. Brun-Buisson, F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, and A. Lepoutre Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274 12 1995 968 974
5. B.S. Crouch, R.G. Wunderink, C.B. Jones, and K.V. Leeper Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa Chest 109 4 1996 1019 1029
6. J. Rello, V. Ausina, M. Ricart, J. Castella, and G. Prats Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia Chest 104 4 1993 1230 1235
7. J. Rello, P. Jubert, J. Valles, A. Artigas, M. Rue, and M.S. Niederman Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas:aeruginosa Clin. Infect. Dis. 23 5 1996 973 978
8. J. Rello, M. Rue, P. Jubert, G. Muses, R. Sonora, and J. Valles Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent Crit. Care Med. 25 11 1997 1862 1867
9. S.C. FitzSimmons The changing epidemiology of cystic fibrosis J. Pediatr. 122 1 1993 1 9
10. H.L. Rocchetta, L.L. Burrows, and J.S. Lam Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa Microbiol. Mol. Biol. Rev. 63 3 1999 523 553
11. J.B. Lyczak, C.L. Cannon, and G.B. Pier Lung infections associated with cystic fibrosis Clin. Microbiol. Rev. 15 2 2002 194 222
12. S. Rajan, and L. Saiman Pulmonary infections in patients with cystic fibrosis Semin. Respir. Infect. 17 1 2002 47 56
13. G.B. Pier CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection Curr. Opin. Microbiol. 5 1 2002 81 86
14. H. Yu, and N.E. Head Persistent infections and immunity in cystic fibrosis Front. Biosci. 7 2002 d442 d457
15. E. Crouch, and J.R. Wright Surfactant proteins a and d and pulmonary host defense Annu. Rev. Physiol. 63 2001 521 554
16. S. Hawgood, and F.R. Poulain The pulmonary collectins and surfactant metabolism Annu. Rev. Physiol. 63 2001 495 519
17. A.M. LeVine, and J.A. Whitsett Pulmonary collectins and innate host defense of the lung Microbes Infect. 3 2 2001 161 166
18. E.C. Crouch Collectins and pulmonary host defense Am. J. Respir. Cell Mol. Biol. 19 2 1998 177 201
19. J. Madsen, A. Kliem, I. Tornoe, K. Skjodt, C. Koch, and U. Holmskov Localization of lung surfactant protein D on mucosal surfaces in human tissues J. Immunol. 164 11 2000 5866 5870
20. T. Madan, P. Eggleton, U. Kishore, P. Strong, S.S. Aggrawal, and P.U. Sarma Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages Infect. Immun. 65 8 1997 3171 3179
21. E.C. Crouch, A. Persson, G.L. Griffin, D. Chang, and R.M. Senior Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes Am. J. Respir. Cell Mol. Biol. 12 4 1995 410 415
22. M.J. Tino, and J.R. Wright Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages Am. J. Physiol. 276 1 Pt 1 1999 L164 L174
23. J.R. Wright, and D.C. Youmans Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage Am. J. Physiol. 264 4 Pt 1 1993 L338 L344
24. G.Z. Cai, G.L. Griffin, R.M. Senior, W.J. Longmore, and M.A. Moxley Recombinant SP-D carbohydrate recognition domain is a chemoattractant for human neutrophils Am. J. Physiol. 276 1 Pt 1 1999 L131 L136
25. K. Kabha, J. Schmegner, Y. Keisari, H. Parolis, J. Schlepper-Schaeffer, and I. Ofek SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages Am. J. Physiol. 272 2 Pt 1 1997 L344 L352
26. T.B. McNeely, and J.D. Coonrod Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages J. Infect. Dis. 167 1 1993 91 97
27. R. Pasula, J.F. Downing, J.R. Wright, D.L. Kachel, T.E. Davis Jr., and W.J. Martin Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages Am. J. Respir. Cell Mol. Biol. 17 2 1997 209 217
28. W.I. Mariencheck, J. Savov, Q. Dong, M.J. Tino, and J.R. Wright Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P.:aeruginosa Am. J. Physiol. 277 4 Pt 1 1999 L777 L786
29. T.R. Korfhagen Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis Am. J. Respir. Cell Mol. Biol. 25 6 2001 668 672
30. H. Manz-Keinke, H. Plattner, and J. Schlepper-Schafer Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages Eur. J. Cell Biol. 57 1 1992 95 100
31. D. Ohmer-Schrock, C. Schlatterer, H. Plattner, and J. Schlepper-Schafer Lung surfactant protein A (SP-A) activates a phosphoinositide-calcium signaling pathway in alveolar macrophages J. Cell Sci. 108 Pt 12 1995 3695 3702
32. K.R. Khubchandani, R.E. Oberley, and J.M. Snyder Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells Am. J. Respir. Cell Mol. Biol. 25 6 2001 699 706
33. S.F. Kuan, K. Rust, and E. Crouch Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage J. Clin. Invest. 90 1 1992 97 106
34. B.L. Lim, J.Y. Wang, U. Holmskov, H.J. Hoppe, and K.B. Reid Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria Biochem. Biophys. Res. Commun. 202 3 1994 1674 1680
35. C.I. Restrepo, Q. Dong, J. Savov, W.I. Mariencheck, and J.R. Wright Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages Am. J. Respir. Cell Mol. Biol. 21 5 1999 576 585
36. A.M. LeVine, K.E. Kurak, M.D. Bruno, J.M. Stark, J.A. Whitsett, and T.R. Korfhagen Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection Am. J. Respir. Cell Mol. Biol. 19 4 1998 700 708
37. A.M. LeVine, J.A. Whitsett, J.A. Gwozdz, T.R. Richardson, J.H. Fisher, and M.S. Burhans Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung J. Immunol. 165 7 2000 3934 3940
38. C. Botas, F. Poulain, J. Akiyama, C. Brown, L. Allen, and J. Goerke Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D Proc. Natl. Acad. Sci. USA 95 20 1998 11869 11874
39. J.F. Van Iwaarden, H. Shimizu, P.H. Van Golde, D.R. Voelker, and L.M. Van Golde Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages Biochem. J. 286 Pt 1 1992 5 8
40. S. Weissbach, A. Neuendank, M. Pettersson, T. Schaberg, and U. Pison Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages Am. J. Physiol. 267 6 Pt 1 1994 L660 L666
41. H. Blau, S. Riklis, J.F. Van Iwaarden, F.X. McCormack, and M. Kalina Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A Am. J. Physiol. 272 6 Pt 1 1997 L1198 L1204
42. J.R. Wright, D.F. Zlogar, J.C. Taylor, T.M. Zlogar, and C.I. Restrepo Effects of endotoxin on surfactant protein A and D stimulation of NO production by alveolar macrophages Am. J. Physiol. 276 4 Pt 1 1999 L650 L658
43. C. Stamme, E. Walsh, and J.R. Wright Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages Am. J. Respir. Cell Mol. Biol. 23 6 2000 772 779
44. J.E. Crowther, V.K. Kutala, P. Kuppusamy, J.S. Ferguson, A.A. Beharka, and J.L. Zweier Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity J. Immunol. 172 11 2004 6866 6874
45. S.G. Kremlev, and D.S. Phelps Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production Am. J. Physiol. 267 6 Pt 1 1994 L712 L719
46. S.G. Kremlev, T.M. Umstead, and D.S. Phelps Surfactant protein A regulates cytokine production in the monocytic cell line THP-1 Am. J. Physiol. 272 5 Pt 1 1997 L996 L1004
47. P. Borron, J.C. McIntosh, T.R. Korfhagen, J.A. Whitsett, J. Taylor, and J.R. Wright Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo Am. J. Physiol. Lung Cell. Mol. Physiol. 278 4 2000 L840 L847
48. S. Rosseau, P. Hammerl, U. Maus, A. Gunther, W. Seeger, and F. Grimminger Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes J. Immunol. 163 8 1999 4495 4502
49. L.S. Engel, J.M. Hill, A.R. Caballero, L.C. Green, and R.J. ÓCallaghan Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa J. Biol. Chem. 273 27 1998 16792 16797
50. A. Lazdunski, J. Guzzo, A. Filloux, M. Bally, and M. Murgier Secretion of extracellular proteins by Pseudomonas aeruginosa Biochimie 72 2-3 1990 147 156
51. P.J. Wilderman, A.I. Vasil, Z. Johnson, M.J. Wilson, H.E. Cunliffe, and I.L. Lamont Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa Infect. Immun. 69 9 2001 5385 5394
52. T.J. Venaille, G. Ryan, and B.W. Robinson Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum Respir. Med. 92 2 1998 233 240
53. I.Y. Haddad, J.P. Crow, P. Hu, Y. Ye, J. Beckman, and S. Matalon Concurrent generation of nitric oxide and superoxide damages surfactant protein A Am. J. Physiol. 267 3 Pt 1 1994 L242 L249
54. T.O. Hirche, E.C. Crouch, M. Espinola, T.J. Brokelman, R.P. Mecham, and N. DeSilva Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain J. Biol. Chem. 279 26 2004 27688 27698
55. W.I. Mariencheck, J.F. Alcorn, S.M. Palmer, and J.R. Wright Pseudomonas aeruginosa elastase degrades surfactant proteins A and D Am. J. Respir. Cell Mol. Biol. 28 4 2003 528 537
56. J.F. Alcorn, and J.R. Wright Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function J. Biol. Chem. 279 29 2004 30871 30879
57. J.L. Malloy, R.A. Veldhuizen, B.A. Thibodeaux, R.J. O'Callaghan, and J.R. Wright Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions Am. J. Physiol. Lung Cell. Mol. Physiol. 288 2 2005 L409 L418
58. G. Lema, D. Dryja, I. Vargas, and G. Enhorning Pseudomonas aeruginosa from patients with cystic fibrosis affects function of pulmonary surfactant Pediatr. Res. 47 1 2000 121 126
59. A.L. Beatty, J.L. Malloy, and J.R. Wright Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro Am. J. Respir. Cell Mol. Biol. 32 2 2005 128 134
60. A.D. Postle, A. Mander, K.B. Reid, J.Y. Wang, S.M. Wright, and M. Moustaki Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis Am. J. Respir. Cell Mol. Biol. 20 1 1999 90 98
61. C. von Bredow, P. Birrer, and M. Griese Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis Eur. Respir. J. 17 4 2001 716 722
62. K.C. Meyer, A. Sharma, R. Brown, M. Weatherly, F.R. Moya, and J. Lewandoski Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis Chest 118 1 2000 164 174
63. R.P. Baughman, R.I. Sternberg, W. Hull, J.A. Buchsbaum, and J. Whitsett Decreased surfactant protein A in patients with bacterial pneumonia Am. Rev. Respir. Dis. 147 3 1993 653 657
64. M. Super, S. Thiel, J. Lu, R.J. Levinsky, and M.W. Turner Association of low levels of mannan-binding protein with a common defect of opsonisation Lancet 2 8674 1989 1236 1239